233.1900 -5.95 (-2.49%)
NSE Jun 05, 2026 15:48 PM
Volume: 1.7M
 

233.19
-2.49%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
Marksans Pharma has gained 24.17% in the last 6 Months
More from Marksans Pharma Ltd.
Recommended